Ausgabe 1/2004
Inhalt (10 Artikel)
Inhibition of Cell Growth, Induction of Apoptosis and Mechanism of Action of the Novel Platinum Compound cis-Diaminechloro-[2-(Diethylamino) Ethyl 4-Amino-Benzoate, N4]-Chloride Platinum (II) Monohydrochloride Monohydrate
Maria A. Mariggiò, Sergio Cafaggi, Massimo Ottone, Brunella Parodi, Maria O. Vannozzi, Vaclav Mandys, Maurizio Viale
The Antiangiogenic Agent Neovastat (Æ-941) Stimulates Tissue Plasminogen Activator Activity
Denis Gingras, Dominique Labelle, Carine Nyalendo, Dominique Boivin, Michel Demeule, Chantal Barthomeuf, Richard Béliveau
Recent Advances in Brain Tumor Therapy: Local Intracerebral Drug Delivery by Polymers
Christopher Guerin, Alessandro Olivi, Jon D. Weingart, H. Christopher Lawson, Henry Brem
Population Pharmacokinetics of Sibrotuzumab, A Novel Therapeutic Monoclonal Antibody, in Cancer Patients
C. Kloft, E-U. Graefe, P. Tanswell, A. M. Scott, R. Hofheinz, A. Amelsberg, M. O. Karlsson
A Phase II Study of Intravenous Exatecan Mesylate (DX-8951f) Administered Daily for Five Days Every Three Weeks to Patients with Metastatic Adenocarcinoma of the Colon or Rectum
Melanie E. Royce, Eric K. Rowinsky, Paulo M. Hoff, John Coyle, Robert DeJager, Richard Pazdur, Leonard B. Saltz
Treatment of AIDS Related Non-Hodgkin's Lymphoma with Combination Mitoguazone Dihydrochloride and Low Dose Chop Chemotherapy: Results of a Phase II study
Anil Tulpule, Byron M. Espina, A. B. Pedro Santabarbara, Maria Palmer, Joanne Schiflett, William Boswell, Susan Smith, Alexandra M. Levine
A Phase II Study of 9-Nitro-Camptothecin in Patients with Previously Treated Metastatic Breast Cancer
Kathy D. Miller, Sharon E. Soule, LaTrice G. Haney, Patricia Guiney, Darryl J. Murry, Luigi Lenaz, Show-Li Sun, George W. Sledge Jr
Phase II Study of Interferon Gamma in Malignant Carcinoid Tumors (E9292): A Trial of the Eastern Cooperative Oncology Group
Keith Stuart, Donna E. Levy, Tom Anderson, Constantine A. Axiotis, Janice P. Dutcher, Andrew Eisenberg, John K. Erban, Al Bowen Benson III
Subcutaneously Administered Recombinant Human Interleukin-2 and Interferon Alfa-2a for Advanced Breast Cancer: A Phase II study of the Cancer and Leukemia Group B (CALGB 9041)
Gretchen Kimmick, Mark J. Ratain, Don Berry, Susan Woolf, Larry Norton, Hyman B. Muss
Gemcitabine and Cisplatin for Patients with Metastatic or Recurrent Esophageal Carcinoma: A Southwest Oncology Group Study
Susan G. Urba, Kari Chansky, Peter J. vanVeldhuizen, Robert E. Pluenneke, Jacqueline K. Benedetti, John S. Macdonald, James L. Abbruzzese